about
Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cellsG-protein coupled receptor expression patterns delineate medulloblastoma subgroupsCombining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in children.Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.Pancreastatin predicts survival in neuroendocrine tumors.90Y-edotreotide for metastatic carcinoid refractory to octreotide.Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors.VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptorsUtility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors.When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors.Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumorsNeuropeptides and gastrointestinal immunity.Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.A radioiodinated MIBG-octreotate conjugate exhibiting enhanced uptake and retention in SSTR2-expressing tumor cells.RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.In vitro modeling of the clinical interactions between octreotide and 111In-pentetreotide: is there evidence of somatostatin receptor downregulation?Caspase 8L, a novel inhibitory isoform of caspase 8, is associated with undifferentiated neuroblastoma.A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.Neuropeptide modulation of the immune response in gut associated lymphoid tissue.Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling.Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors.A DOTA-peptide conjugate by copper-free click chemistry.GIPR expression in gastric and duodenal neuroendocrine tumors.Distribution and functional significance of somatostatin receptors in malignant melanoma.111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.Age-dependent levels of plasma neuropeptides in normal children.A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon.Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies.Expression of somatostatin receptors 1 and 2 in human choroid plexus and arachnoid granulations: implications for idiopathic intracranial hypertension.Expression and fine mapping of murine vasoactive intestinal peptide receptor 1.Atypical teratoid/rhabdoid tumor case report: treatment with surgical excision, radiation therapy, and alternative medicines.Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.ECM1 expression in thyroid tumors--a comparison of real-time RT-PCR and IHC.Modulation of cyclic guanosine monophosphate production during Escherichia coli septic shock.Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.Choroidal schwannoma in a 6-month-old girlComparison of vasoactive intestinal peptide-mediated protein phosphorylation in human lymphoblasts and colonic epithelial cells
P50
Q28142976-15C334AD-947C-492F-B65B-67C52639563FQ28302285-BBA48B18-6557-4296-8042-3FDC88AF9F42Q31160520-72210EFF-C3AF-4E6B-83D7-E5B5F6D5E6A5Q33888431-1B5EEAAC-94F4-4361-843A-D1F8E1B24647Q34016884-1A77620E-E068-4F3E-889C-44E5558F6858Q34101554-E46FC44C-B929-438C-A321-467347E138B9Q34610406-9C6A4FBF-929B-4181-BB7D-AE6E14541E49Q35675435-5A0EA303-0F8D-47C3-88D4-5E5C85CCAE74Q37054934-DD533D9D-98C1-4A23-B7F5-F0B4D39CCC9EQ37122608-FE8367E1-1F88-4D95-B224-6E852884630EQ37151615-D873E1D6-52F3-4A35-8468-2B98C839CB4CQ37496864-18EDCD8C-72CE-403D-AD84-03D5D2126ECCQ37504159-93A44DE8-2EE5-40C1-BF62-EEAF5D4D55DFQ37694773-020543F8-EE99-4929-BFB3-358F5254D5CCQ38170366-A6AC23AB-7A5D-422B-95D8-FE9C962BA76BQ38382330-A99ECFB8-6338-4735-AD93-33FA65A6B796Q40057851-D1BF617A-0A59-4D58-9CB3-8263B0BB4D3AQ40208670-5046481F-3FDB-4088-9BAB-7E2B3180D23DQ40321376-3E4F0446-4F63-4E21-8C9E-43F94C929B84Q40336712-EC68F453-D58C-4889-9BDF-0C7CFC231F7EQ40647363-29B0C773-7D17-4F55-83EC-36B0D7463335Q41252409-1DD8BCE2-E467-4DA1-A610-A7EA4CC7D076Q41635330-DF137778-8109-466B-944B-259927DE61AEQ41851778-0252E486-2C29-4921-890F-D8A4CA38A290Q42039958-821D8D5C-FD91-4EA1-AFDB-53C64A0B63AFQ42734654-40C61D2E-0710-4C4C-BC92-6EF61619BF5DQ43601966-F301888F-0781-4BA8-A4EB-EC9647CDE9C3Q44157040-D70D5E56-06C5-40B9-A4AF-EFD49EAE9205Q44200153-4325E7CC-91D8-4D56-8E3A-C6CA8299D3E8Q44451615-4E7E605A-1F9E-4BFC-966D-D46C19C85E88Q48227840-208FA04C-2386-4BAD-A5F7-EA52F8043E15Q48449401-58EEE0B9-0224-4186-97E0-12A4FE4045CFQ48681364-D0C2D0AA-B4F7-42B4-B86E-A2A699542D93Q48946791-C3A5E24F-40C8-414B-980B-1F1ABCBFEE6FQ52914636-300205D2-23B0-49A9-9FDA-8D42144CB62CQ54539849-0279247B-1CA5-434B-8535-9AC149266E32Q54636685-7035D47F-B898-4AE0-8898-9CA9CBF14F06Q55474087-6E25636D-097B-417F-B195-8E1CD8F2C259Q57183421-C3341B09-A91F-4F3E-AB63-5B547F2D0A87Q69706122-4BF8C8DC-3E2A-40E9-870C-86443306B3F9
P50
description
researcher ORCID ID = 0000-0003-0690-1160
@en
wetenschapper
@nl
name
M Sue O'Dorisio
@ast
M Sue O'Dorisio
@en
M Sue O'Dorisio
@es
M Sue O'Dorisio
@nl
type
label
M Sue O'Dorisio
@ast
M Sue O'Dorisio
@en
M Sue O'Dorisio
@es
M Sue O'Dorisio
@nl
prefLabel
M Sue O'Dorisio
@ast
M Sue O'Dorisio
@en
M Sue O'Dorisio
@es
M Sue O'Dorisio
@nl
P1006
P214
P1006
P106
P1153
57189809737
P214
P31
P496
0000-0003-0690-1160
P7859
lccn-n89108378